Make practice questions usign these notes: Hypersensitivity is an exaggerated normal…
- User
Make practice questions usign these notes: Hypersensitivity is an exaggerated normal adaptive immune response Can cause damage/ fatal responses in response to antigens that stimulate these responses Exaggerated response to foreign antigens Inappropriate response to self-antigens ABCD → Allergies B-antiBodies C- immune Complexes D- Delayed T cell Type I- IgE mediated hypersensitivity also called immediate hypersensitivity Cell surface-bound antibody bridged by binding antigen Type II- antibody-mediated hypersensitivity Antibody-antigen mediated cytotoxicity Ab binds inappropriately to ag on cell surface and activates complement Type III- immune complex-mediated hypersensitivity Antibody-antigen complex in the endothelium ICs accumulate in circulation or on tissue and active complement Type IV- T cell-mediated hypersensitivity also called delayed-type hypersensitivity
Type I Response- localized (atopic) and systemic (anaphylactic) IgE mediated- IgE is mostly found in tissues not circulation Allergen- antigen that induces an allergic response People predisposed to develop IgE antibodies to harmless antigens are called atopic Can be due to genetics and environmental factors First exposure makes IgE and the person gets sensitized to the antigen/allergen Second exposure is when hypersensitivity occurs
Main effector cells for IgE response are mast cells Mast cells are in blood vessels in connective tissue and lining of gut and lungs Crosslinking of two IgE molecules induces degranulation and is immediate, this also causes all mast cells in the area to degranulate. These mediators also recruit other immune cells to the site of mast cells.
Inflammatory mediators released by mast cells are what cause the symptoms. Preformed mediators- stored in granules and immediately released Histamine- increases vascular permeability TNF-α- promotes inflammation; preformed and newly synthesized Enzymes such as tryptase and chymase that remodel matrix Newly synthesized mediators- chemokines and cytokines that amplify the response and are made after activation Eicanosanoids -lipid mediators Leukotrienes- like histamine but more potent. Histamine starts reaction but leukotrienes responsible for inflammation, smooth muscle contraction, airway constriction, mucus secretion
Prostaglandins Platelet aggregating factor- induces shock-like symptoms; augments mast cell activity Histamine and leukotrienes leads to bronchoconstriction and vasodilationEosinophils- migrate to tissues in response to chemokines and the chemokines/cytokines at the site of inflammation induce expression of eosinophil FcεlRI. KNOW eosinophils are highly toxic
IgE binds eosinophil and preformed compounds are expressed first Synthesis of cytokines, leukotrienes, PGD amplify response Major basic protein (MBP)- poisons parasites and host cells, induces mast cells to release histamineAllergic reactions- Wheal and flare Anaphylaxis Allergic rhinitis/ asthma Hives/Eczema Food allergies Allergens- exposed by injection, inhalation, contact, ingestion Are small soluble proteins present in dried-up particlesGood allergens are: proteins, low molecular weight, high solubility, stable, and low dose, often proteases Early and late response= In sensitized people: Exposure to allergen causes immediate degranulation of mast cells Early reaction is due to preformed and newly made mediators (seconds to minutes) Results in Wheal and Flare Reaction Wheal is histamine → rapid increase in vascular permeability allowing fluid to leak out of vessels causing local swelling Flare is local redding due to increased blood flow Late reaction is result of continued synthesis and release of mediators by mast cells Swelling due to leukotrienes, chemokines, and cytokines Depends on allergen dose Increased edema that peaks 3-9 hours and can last 24 hours The second exposure location will determine the outcome of the IgE reaction Localized reaction- Only mast cells at the site of allergen Inhaled or ingested- mucosal mast cells Penetrated- connective tissue mast cells Anatomy determines how long the reaction lasts Airborne- respiratory tract Food- GI tract Bites/stings/wounds- blood and CT The strength of reaction depends on number of IgE present
Treatments for Type I Omalizumab- anti-IgE Fc antibodies Block IL4/R or IL5/R Corticosteroids- antiinflammatory
Type II
Antibody-mediated by IgG or IgM Binding of antibody directly to antigen on cell or tissue surface Reactions: Complement- lysis or opsonization with C3b and antibodies and destruction by macrophages or neutrophils. Ex- wrong blood type transfusion Antibody-mediated phagocytosis Antibody-mediated cellular dysfunction- antibodies block a receptor and prevent its function. Ex- Myasthenia gravis inhibits the receptor for Ach.
Type III Systemic reaction, unlike Type II which is local or tissue specific. Caused by Deposition of antigen-antibody complexes Examples- Subcutaneous type III- Arthus reaction Deposition of immune complexes Systemic Type III- Serum sickness Vasculitis, nephritis, arthritis, glomerulonephritis
Type IV T cell-mediated and delayed Causes- tuberculin, insect venom, metals, and plant toxins Two types: Damage due to inflammation response and tissue destruction due to TH1 and macrophages Damage due to direct cytotoxic activity of CD8+ T cells
- Assistant
-
What describes an exaggerated normal adaptive immune response that can lead to potentially fatal responses upon exposure to antigens?
- A) Hypersensitivity
- B) Immunodeficiency
- C) Autoimmunity
- D) Innate immunity
-
Which of the following is NOT a classification of hypersensitivity reactions?
- A) Allergies
- B) B-antiBodies
- C) Immune thrombocytopenia
- D) Delayed T cell response
-
Type I hypersensitivity is mediated by which immunoglobulin?
- A) IgG
- B) IgM
- C) IgE
- D) IgA
-
What is the mechanism of action in Type II hypersensitivity reactions?
- A) Immediate degranulation of mast cells
- B) Antibody-antigen mediated cytotoxicity
- C) T cell-mediated cytotoxicity
- D) Formation and deposition of immune complexes
-
Which type of hypersensitivity reaction is known for the formation of immune complexes in the endothelium?
- A) Type I
- B) Type II
- C) Type III
- D) Type IV
-
What are the main effector cells in a Type I IgE mediated hypersensitivity reaction?
- A) Neutrophils
- B) Eosinophils
- C) Mast cells
- D) Macrophages
-
Which mediator is responsible for increasing vascular permeability in Type I hypersensitivity reactions?
- A) Eicosanoids
- B) TNF-α
- C) Histamine
- D) Major basic protein
-
In Type II hypersensitivity reactions, what could be a potential result of complement activation?
- A) Immediate mast cell degranulation
- B) Lysis or opsonization leading to destruction by macrophages or neutrophils
- C) Formation of immune complexes leading to vasculitis
- D) Direct cytotoxic activity of CD8+ T cells
-
What is the primary cause of symptoms in a Type IV hypersensitivity reaction?
- A) Immediate release of histamine
- B) Antibody-mediated cellular dysfunction
- C) Deposition of antigen-antibody complexes
- D) T-cell mediated delayed response
-
Which treatment option is specifically targeted for Type I hypersensitivity reactions?
- A) Omalizumab, an anti-IgE antibody
- B) Intravenous immunoglobulin
- C) Broad-spectrum antibiotics
- D) Antiretroviral therapy
-
The phenomenon of wheal and flare reaction is characteristic of which type of hypersensitivity?
- A) Type I
- B) Type II
- C) Type III
- D) Type IV
-
What defines individuals who are predisposed to develop IgE antibodies to harmless antigens?
- A) Autoimmune
- B) Atopic
- C) Immunocompromised
- D) Hypergammaglobulinemic
-
Why are eosinophils considered highly toxic in the context of Type I hypersensitivity reactions?
- A) They produce histamine, which leads to anaphylaxis.
- B) They directly attack and destroy mast cells, leading to severe tissue damage.
- C) They release major basic protein and other mediators that poison parasites and host cells.
- D) They inhibit the action of leukotrienes and prostaglandins, leading to uncontrolled inflammation.
-
What distinguishes a systemic Type III hypersensitivity reaction like serum sickness from a localized reaction such as an Arthus reaction?
- A) The involvement of T cells in systemic reactions.
- B) The deposition of immune complexes in specific tissues versus widespread circulation.
- C) The exclusive involvement of IgE in systemic reactions.
- D) The inability of systemic reactions to induce complement activation.
-
How does blocking IL-4/R or IL-5/R serve as a treatment for Type I hypersensitivity reactions?
- A) By reducing T cell-mediated cytotoxicity.
- B) By preventing the formation of immune complexes.
- C) By inhibiting the pathways that lead to IgE production and inflammation.
- D) By directly neutralizing antigens before they can bind to mast cells.
-
- User
What are the right answers to those questions?
- Assistant
Here are the correct answers to the practice questions:
-
A) Hypersensitivity
-
C) Immune thrombocytopenia - This is not a classification of hypersensitivity reactions; ABCD (Allergies, B-antiBodies, C- immune Complexes, D- Delayed T cell) references the classifications.
-
C) IgE - Type I hypersensitivity is IgE mediated.
-
B) Antibody-antigen mediated cytotoxicity - This is the characteristic mechanism of Type II hypersensitivity reactions.
-
C) Type III - Immune complex-mediated hypersensitivity involves the formation of immune complexes in the endothelium.
-
C) Mast cells - They are the main effector cells in a Type I IgE mediated hypersensitivity reaction.
-
C) Histamine - It is responsible for increasing vascular permeability in Type I hypersensitivity reactions.
-
B) Lysis or opsonization leading to destruction by macrophages or neutrophils - This is because of complement activation in Type II hypersensitivity reactions.
-
D) T-cell mediated delayed response - This is the primary cause of symptoms in Type IV hypersensitivity reactions.
-
A) Omalizumab, an anti-IgE antibody - This treatment is specifically targeted for Type I hypersensitivity reactions.
-
A) Type I - The phenomenon of wheal and flare reaction is characteristic of this type of hypersensitivity.
-
B) Atopic - Individuals predisposed to develop IgE antibodies to harmless antigens are called atopic.
-
C) They release major basic protein and other mediators that poison parasites and host cells. - This describes why eosinophils are considered highly toxic in the context of Type I hypersensitivity reactions.
-
B) The deposition of immune complexes in specific tissues versus widespread circulation. - This distinguishes a systemic Type III hypersensitivity reaction like serum sickness from a localized reaction such as an Arthus reaction.
-
C) By inhibiting the pathways that lead to IgE production and inflammation. - Blocking IL-4/R or IL-5/R serves as a treatment for Type I hypersensitivity by targeting the pathways involved in IgE production and the inflammatory response.
-